Tvardi Therapeutics Files Prospectus For Offering $200M Mixed Shelf

Benzinga Newsdesk www.benzinga.com Neutral 93.6%

Neg 0% Neu 93.6% Pos 0%

https://www.sec.gov/Archives/edgar/data/1346830/000110465926054113/tm2613101-1_s3.htm

Comments

No comments yet. Be the first!